{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:03:14Z","timestamp":1759104194772,"version":"3.44.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1016\/j.jneuroim.2010.05.028","type":"journal-article","created":{"date-parts":[[2010,6,11]],"date-time":"2010-06-11T05:58:44Z","timestamp":1276235924000},"page":"27-37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Type I interferon signals control Theiler's virus infection site, cellular infiltration and T cell stimulation in the CNS"],"prefix":"10.1016","volume":"226","author":[{"given":"Young-Hee","family":"Jin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanqiu","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung Jae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alyson C.","family":"Fuller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bongsu","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gwen","family":"Goings","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen D.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byung S.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2010.05.028_bib1","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S1074-7613(01)00154-6","article-title":"Interferons alpha and beta as immune regulators\u2014a new look","volume":"14","author":"Biron","year":"2001","journal-title":"Immunity"},{"key":"10.1016\/j.jneuroim.2010.05.028_bib2","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1146\/annurev.immunol.17.1.189","article-title":"Natural killer cells in antiviral defense: function and regulation by innate cytokines","volume":"17","author":"Biron","year":"1999","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jneuroim.2010.05.028_bib3","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1084\/jem.178.5.1655","article-title":"Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells","volume":"178","author":"Brinkmann","year":"1993","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2010.05.028_bib4","doi-asserted-by":"crossref","first-page":"4465","DOI":"10.4049\/jimmunol.174.8.4465","article-title":"Type I IFNs provide a third signal to CD8 T cells to stimulate clonal expansion and differentiation","volume":"174","author":"Curtsinger","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2010.05.028_bib5","doi-asserted-by":"crossref","first-page":"7835","DOI":"10.1073\/pnas.0602460103","article-title":"Neurons produce type I interferon during viral encephalitis","volume":"103","author":"Delhaye","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jneuroim.2010.05.028_bib6","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/ni1213","article-title":"A critical function for type I interferons in cancer immunoediting","volume":"6","author":"Dunn","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jneuroim.2010.05.028_bib7","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1084\/jem.181.6.2069","article-title":"Theiler's virus infection of 129Sv mice that lack the interferon alpha\/beta or interferon gamma receptors","volume":"181","author":"Fiette","year":"1995","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2010.05.028_bib8","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1182\/blood-2005-07-2913","article-title":"CD38 orchestrates migration, survival, and Th1 immune response of human mature dendritic cells","volume":"107","author":"Frasca","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jneuroim.2010.05.028_bib9","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1038\/15200","article-title":"Natural adjuvants: endogenous activators of dendritic cells","volume":"5","author":"Gallucci","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.jneuroim.2010.05.028_bib10","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1126\/science.1125676","article-title":"Type 1 interferons and the virus-host relationship: a lesson in detente","volume":"312","author":"Garcia-Sastre","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.jneuroim.2010.05.028_bib11","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.2165\/00003495-200161120-00001","article-title":"Interferon-beta therapy in multiple sclerosis: evidence for a clinically relevant dose response","volume":"61","author":"Goodin","year":"2001","journal-title":"Drugs"},{"key":"10.1016\/j.jneuroim.2010.05.028_bib12","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.4049\/jimmunol.179.3.1438","article-title":"Controls for lung dendritic cell maturation and migration during respiratory viral infection","volume":"179","author":"Grayson","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2010.05.028_bib13","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.4049\/jimmunol.176.6.3315","article-title":"Cutting edge: the direct action of type I IFN on CD4 T cells is critical for sustaining clonal expansion in response to a viral but not a bacterial infection","volume":"176","author":"Havenar-Daughton","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2010.05.028_bib14","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.1371\/journal.ppat.0030124","article-title":"Role of dendritic cells in differential susceptibility to viral demyelinating disease","volume":"3","author":"Hou","year":"2007","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jneuroim.2010.05.028_bib15","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.1128\/jvi.68.5.3324-3333.1994","article-title":"Analysis of antibody responses to predominant linear epitopes of Theiler's murine encephalomyelitis virus","volume":"68","author":"Inoue","year":"1994","journal-title":"J. Virol."},{"key":"10.1016\/j.jneuroim.2010.05.028_bib16","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1128\/JVI.01794-07","article-title":"Type I interferons are essential in controlling neurotropic coronavirus infection irrespective of functional CD8 T cells","volume":"82","author":"Ireland","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.jneuroim.2010.05.028_bib17","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1098\/rspb.1957.0048","article-title":"Virus interference. I. The interferon","volume":"147","author":"Isaacs","year":"1957","journal-title":"Proc. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.jneuroim.2010.05.028_bib18","doi-asserted-by":"crossref","first-page":"11690","DOI":"10.1128\/JVI.01034-07","article-title":"Differential virus replication, cytokine production, and antigen-presenting function by microglia from susceptible and resistant mice infected with Theiler's virus","volume":"81","author":"Jin","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.jneuroim.2010.05.028_bib19","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1002\/glia.20668","article-title":"Replication of Theiler's virus requires NF-kappaB-activation: higher viral replication and spreading in astrocytes from susceptible mice","volume":"56","author":"Kang","year":"2008","journal-title":"Glia"},{"key":"10.1016\/j.jneuroim.2010.05.028_bib20","first-page":"373","article-title":"Pathogenic immunity in Theiler's virus-induced demyelinating disease: a viral model for multiple sclerosis","volume":"48","author":"Kim","year":"2000","journal-title":"Arch. Immunol. Ther. Exp."},{"key":"10.1016\/j.jneuroim.2010.05.028_bib21","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1084\/jem.20050821","article-title":"Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection","volume":"202","author":"Kolumam","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2010.05.028_bib22","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.4049\/jimmunol.165.7.3571","article-title":"Distinct requirements for IFNs and STAT1 in NK cell function","volume":"165","author":"Lee","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2010.05.028_bib23","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1002\/eji.200535785","article-title":"Initial capsid-specific CD4(+) T cell responses protect against Theiler's murine encephalomyelitisvirus-induced demyelinating disease","volume":"36","author":"Mohindru","year":"2006","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jneuroim.2010.05.028_bib24","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1182\/blood.V99.9.3263","article-title":"Type I interferons produced by dendritic cells promote their phenotypic and functional activation","volume":"99","author":"Montoya","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jneuroim.2010.05.028_bib25","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1126\/science.8009221","article-title":"Functional role of type I and type II interferons in antiviral defense","volume":"264","author":"Muller","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.jneuroim.2010.05.028_bib26","doi-asserted-by":"crossref","first-page":"4279","DOI":"10.4049\/jimmunol.169.8.4279","article-title":"Coordinated and distinct roles for IFN-alpha beta, IL-12, and IL-15 regulation of NK cell responses to viral infection","volume":"169","author":"Nguyen","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2010.05.028_bib27","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1002\/eji.200838437","article-title":"IFN-beta regulates CD73 and adenosine expression at the blood\u2013brain barrier","volume":"38","author":"Niemela","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jneuroim.2010.05.028_bib28","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/(SICI)1097-4547(20000301)59:5<661::AID-JNR9>3.0.CO;2-E","article-title":"Short-term treatment with interferon-alpha\/beta promotes remyelination, whereas long-term treatment aggravates demyelination in a murine model of multiple sclerosis","volume":"59","author":"Njenga","year":"2000","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.jneuroim.2010.05.028_bib29","doi-asserted-by":"crossref","first-page":"6322","DOI":"10.1128\/JVI.77.11.6322-6331.2003","article-title":"Infection with Theiler's murine encephalomyelitis virus directly induces proinflammatory cytokines in primary astrocytes via NF-kappaB activation: potential role for the initiation of demyelinating disease","volume":"77","author":"Palma","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.jneuroim.2010.05.028_bib30","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.0105-2896.2004.00204.x","article-title":"Interferons, interferon-like cytokines, and their receptors","volume":"202","author":"Pestka","year":"2004","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jneuroim.2010.05.028_bib31","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.immuni.2008.03.011","article-title":"Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system","volume":"28","author":"Prinz","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.jneuroim.2010.05.028_bib32","doi-asserted-by":"crossref","first-page":"4497","DOI":"10.4049\/jimmunol.155.9.4497","article-title":"Treatment with bacterial LPS renders genetically resistant C57BL\/6 mice susceptible to Theiler's virus-induced demyelinating disease","volume":"155","author":"Pullen","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2010.05.028_bib33","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/ana.410400412","article-title":"Interferon beta induces interleukin-10 expression: relevance to multiple sclerosis","volume":"40","author":"Rudick","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2010.05.028_bib34","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1084\/jem.191.10.1777","article-title":"Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice","volume":"191","author":"Santini","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2010.05.028_bib35","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1212\/WNL.45.2.367","article-title":"Differential effects of beta and gamma interferons on expression of major histocompatibility complex antigens and intercellular adhesion molecule-1 in cultured fetal human astrocytes","volume":"45","author":"Satoh","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2010.05.028_bib36","first-page":"57","article-title":"Location and distribution of virus antigen in the central nervous system of mice persistently infected with Theiler's virus","volume":"64","author":"Sethi","year":"1983","journal-title":"Br. J. Exp. Pathol."},{"key":"10.1016\/j.jneuroim.2010.05.028_bib37","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/glia.20346","article-title":"Induction of chemokine and cytokine genes in astrocytes following infection with Theiler's murine encephalomyelitis virus is mediated by the Toll-like receptor 3","volume":"53","author":"So","year":"2006","journal-title":"Glia"},{"key":"10.1016\/j.jneuroim.2010.05.028_bib38","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/ana.410370511","article-title":"The effect of interferon-beta on blood\u2013brain barrier disruptions demonstrated by contrast-enhanced magnetic resonance imaging in relapsing-remitting multiple sclerosis","volume":"37","author":"Stone","year":"1995","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2010.05.028_bib39","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/j.1462-5822.2006.00716.x","article-title":"Interferon signalling network in innate defence","volume":"8","author":"Takaoka","year":"2006","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.jneuroim.2010.05.028_bib40","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1126\/science.288.5475.2357","article-title":"Cross talk between interferon-gamma and -alpha\/beta signaling components in caveolar membrane domains","volume":"288","author":"Takaoka","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.jneuroim.2010.05.028_bib41","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.4049\/jimmunol.177.6.3542","article-title":"IFN-beta inhibits T cell activation capacity of central nervous system APCs","volume":"177","author":"Teige","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2010.05.028_bib42","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1126\/science.80.2066.122.b","article-title":"Spontaneous encephalomyelitis of mice\u2014a new virus disease","volume":"80","author":"Theiler","year":"1934","journal-title":"Science"},{"key":"10.1016\/j.jneuroim.2010.05.028_bib43","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1146\/annurev.immunol.23.021704.115843","article-title":"Type I interferons (alpha\/beta) in immunity and autoimmunity","volume":"23","author":"Theofilopoulos","year":"2005","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jneuroim.2010.05.028_bib44","doi-asserted-by":"crossref","first-page":"4173","DOI":"10.4049\/jimmunol.168.8.4173","article-title":"De novo central nervous system processing of myelin antigen is required for the initiation of experimental autoimmune encephalomyelitis","volume":"168","author":"Tompkins","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2010.05.028_bib45","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/PL00007862","article-title":"Interferon beta1a (Avonex) treatment in multiple sclerosis: similarity of effect on progression of disability in patients with mild and moderate disability","volume":"249","author":"Vermersch","year":"2002","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2010.05.028_bib46","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/ana.1096","article-title":"Complex immunomodulatory effects of interferon-beta in multiple sclerosis include the upregulation of T helper 1-associated marker genes","volume":"50","author":"Wandinger","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2010.05.028_bib47","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jns.2006.10.008","article-title":"Interferon beta-1b exacerbates multiple sclerosis with severe optic nerve and spinal cord demyelination","volume":"252","author":"Warabi","year":"2007","journal-title":"J. Neurol. Sci."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572810002122?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572810002122?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:14:24Z","timestamp":1759047264000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572810002122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":47,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S0165572810002122"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2010.05.028","relation":{},"ISSN":["0165-5728"],"issn-type":[{"type":"print","value":"0165-5728"}],"subject":[],"published":{"date-parts":[[2010,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Type I interferon signals control Theiler's virus infection site, cellular infiltration and T cell stimulation in the CNS","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2010.05.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}